# FDA 483 - KEDPLASMA LLC - April 16, 2026

Source: https://www.keypedia.com/records/483/kedplasma-llc/02acc038-0fce-40fc-bfa7-e2eaa100de0c

> FDA 483 for KEDPLASMA LLC on April 16, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: KEDPLASMA LLC
- Inspection Date: 2026-04-16
- Product Type: biologics
- Office Name: New Jersey District Office
- Summary: An FDA inspection of KEDPLASMA LLC in Cinnaminson, NJ, revealed a significant failure in reporting. The firm did not submit a Biological Product Deviation report after allowing a donor with an unacceptable address to make continuous source plasma donations, and subsequently distributing these units. This indicates a lapse in compliance with regulatory reporting requirements for biological products.

## Related Officers

- [Kish Bolden](https://www.keypedia.com/people/kish-bolden/e24957d4-927f-40c7-a7ca-860fedce2e3f)

Company: https://www.keypedia.com/companies/kedplasma-llc/a32fe274-c71b-4b35-9507-a7e98032942c

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248